Increased claudin-1 protein expression contributes to tumorigenesis in ulcerative colitis-associated colorectal cancer

Anticancer Research

Volumn 30, Issue 8, 2010, Pages 3181-3186

  Kinugasa, Tetsushi ^a   Akagi, Yoshito ^a   Yoshida, Takefumi ^a   Ryu, Yasuhiko ^a   Shiratuchi, Ichitarou ^a   Ishibashi, Nobuya ^a   Shirouzu, Kazuo ^a  

^a KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Claudin 1; Surveillance; UC associated colorectal cancer; Ulcerative colitis

Indexed keywords

BETA CATENIN; CLAUDIN 1; MEMBRANE PROTEIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; COLON MUCOSA; COLON RESECTION; COLORECTAL CANCER; DISEASE ASSOCIATION; DISEASE DURATION; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ILEOANAL ANASTOMOSIS; ILEOSTOMY; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROID THERAPY; TIGHT JUNCTION; TREATMENT INDICATION; ULCERATIVE COLITIS; UPREGULATION; COLORECTAL TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; COLITIS, ULCERATIVE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MEMBRANE PROTEINS; MIDDLE AGED; YOUNG ADULT;

EID: 77957355677     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Choi PM and Zelig MP: Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. Gut 35: 950-954, 1994. (Pubitemid 24980354)
2. Eaden JA, Abrams KR and Mayberry JF: The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 48: 526-535, 2001.
3. Itzkowitz SH and Yio X: Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am J Physiol Gastrointest Liver Physiol 287: G7-17, 2004.
4. Ullman T, Croog V, Harpaz N, Sachar D and Itzkowitz S: Progression of flat low-grade dysplasia to advanced neoplasia in patients with ulcerative colitis. Gastroenterology 125: 1311-1319, 2003. (Pubitemid 37409751)
5. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D, Kirk L, Litin S and Simmang C: Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. Gastroenterology 124: 544-560, 2003.
6. Eaden JA and Mayberry JF: Guidelines for screening and surveillance of asymptomatic colorectal cancer in patients with inflammatory bowel disease. Gut 51(Suppl 5): V10-12, 2002.
7. Lutgens MW, Vleggaar FP, Schipper ME, Stokkers PC, van der Woude CJ, Hommes DW, de Jong DJ, Dijkstra G, van Bodegraven AA, Oldenburg B and Samsom M: High frequency of early colorectal cancer in inflammatory bowel disease. Gut 57: 1246-1251, 2008.
8. Zisman TL and Rubin DT: Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol 14: 2662-2669, 2008.
9. van Rijn AF, Fockens P, Siersema PD and Oldenburg B: Adherence to surveillance guidelines for dysplasia and colorectal carcinoma in ulcerative and Crohn's colitis patients in the Netherlands. World J Gastroenterol 15: 226-230, 2009.
10. Furuse M, Hirase T, Itoh M, Nagafuchi A, Yonemura S and Tsukita S: Occludin: a novel integral membrane protein localizing at tight junctions. J Cell Biol 123: 1777-1788, 1993.
11. Saitou M, Fujimoto K, Doi Y, Itoh M, Fujimoto T, Furuse M, Takano H, Noda T and Tsukita S: Occludin-deficient embryonic stem cells can differentiate into polarized epithelial cells bearing tight junctions. J Cell Biol 141: 397-408, 1998.
12. Furuse M, Fujita K, Hiiragi T, Fujimoto K and Tsukita S: Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141: 1539-1550, 1998. (Pubitemid 28309169)
13. Tsukita S and Furuse M: Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 149: 13-16, 2000.
14. Itoh M, Furuse M, Morita K, Kubota K, Saitou M and Tsukita S: Direct binding of three tight junction-associated MAGUKs, ZO-1, ZO-2, and ZO-3, with the COOH termini of claudins. J Cell Biol 147: 1351-1363, 1999.
15. Hamazaki Y, Itoh M, Sasaki H, Furuse M and Tsukita S: Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule. J Biol Chem 277: 455-461, 2002.
16. Kinugasa T, Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T, Futami K, Yamashita Y, Hachimine K, Maekawa S, Nabeshima K and Iwasaki H: Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res 27: 3729-3734, 2007.
17. Huo Q, Kinugasa T, Wang L, Huang J, Zhao J, Shibaguchi H, Kuroki M, Tanaka T, Yamashita Y, Nabeshima K and Iwasaki H: Claudin-1 protein is a major factor involved in the tumorigenesis of colorectal cancer. Anticancer Res 29: 851-857, 2009.
18. Hewitt KJ, Agarwal R and Morin PJ: The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6: 186, 2006. (Pubitemid 46277109)
19. Cheung ST, Leung KL, Ip YC, Chen X, Fong DY, Ng IO, Fan ST and So S: Claudin-10 expression level is associated with recurrence of primary hepatocellular carcinoma. Clin Cancer Res 11: 551-556, 2005.
20. Howe HL, Wu X, Ries LA, Cokkinides V, Ahmed F, Jemal A, Miller B, Williams M, Ward E, Wingo PA, Ramirez A and Edwards BK: Annual report to the nation on the status of cancer, 1975-2003, featuring cancer among U.S. Hispanic/Latino populations. Cancer 107: 1711-1742, 2006.
21. Peto J: Cancer epidemiology in the last century and the next decade. Nature 411: 390-395, 2001.
22. Tobioka H, Isomura H, Kokai Y and Sawada N: Polarized distribution of carcinoembryonic antigen is associated with a tight junction molecule in human colorectal adenocarcinoma. J Pathol 198: 207-212, 2002. (Pubitemid 35243878)
23. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus, 7th edition. Tokyo, Japan: Kanehara Shuppan; 2006.
24. Kinugasa T, Sakaguchi T, Gu X and Reinecker HC: Claudins regulate the intestinal barrier in response to immune mediators. Gastroenterology 118: 1001-1011, 2000.
25. Eaden J: Review article: colorectal carcinoma and inflammatory bowel disease. Aliment Pharmacol Ther 20(Suppl 4): 24-30, 2004.
26. Bernstein CN, Blanchard JF, Kliewer E and Wajda A: Cancer risk in patients with inflammatory bowel disease: a population-based study. Cancer 91: 854-862, 2001. (Pubitemid 32173312)
27. Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I and Forbes A: Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 126: 451-459, 2004.
28. Vagefi PA and Longo WE: Colorectal cancer in patients with inflammatory bowel disease. Clin Colorectal Cancer 4: 313-319, 2005.
29. Redston MS, Papadopoulos N, Caldas C, Kinzler KW and Kern SE: Common occurrence of APC and K-ras gene mutations in the spectrum of colitis-associated neoplasias. Gastroenterology 108: 383-392, 1995.
30. Burmer GC, Levine DS, Kulander BG, Haggitt RC, Rubin CE and Rabinovitch PS: c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology 99: 416-420, 1990. (Pubitemid 20219098)
31. Kern SE, Redston M, Seymour AB, Caldas C, Powell SM, Kornacki S and Kinzler KW: Molecular genetic profiles of colitis-associated neoplasms. Gastroenterology 107: 420-428, 1994.
32. Tarmin L, Yin J, Harpaz N, Kozam M, Noordzij J, Antonio LB, Jiang HY, Chan O, Cymes K and Meltzer SJ: Adenomatous polyposis coli gene mutations in ulcerative colitis-associated dysplasias and cancers versus sporadic colon neoplasms. Cancer Res 55: 2035-2038, 1995.
33. Brentnall TA, Crispin DA, Rabinovitch PS, Haggitt RC, Rubin CE, Stevens AC and Burmer GC: Mutations in the p53 gene: an early marker of neoplastic progression in ulcerative colitis. Gastroenterology 107: 369-378, 1994.
34. Burmer GC, Rabinovitch PS, Haggitt RC, Crispin DA, Brentnall TA, Kolli VR, Stevens AC and Rubin CE: Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology 103: 1602-1610, 1992.
35. Issa JP, Ahuja N, Toyota M, Bronner MP and Brentnall TA: Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61: 3573-3577, 2001.
36. INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 58: 3942-3945, 1998.
37. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK and Beauchamp RD: Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 115: 1765-1776, 2005. (Pubitemid 40979715)
38. Soini Y: Expression of claudins 1, 2, 3, 4, 5 and 7 in various types of tumours. Histopathology 46: 551-560, 2005.
39. Swisshelm K, Macek R and Kubbies M: Role of claudins in tumorigenesis. Adv Drug Deliv Rev 57: 919-928, 2005.
40. Morin PJ: Claudin proteins in human cancer: promising new targets for diagnosis and therapy. Cancer Res 65: 9603-9606, 2005.
41. Michl P, Barth C, Buchholz M, Lerch MM, Rolke M, Holzmann KH, Menke A, Fensterer H, Giehl K, Lohr M, Leder G, Iwamura T, Adler G and Gress TM: Claudin-4 expression decreases invasiveness and metastatic potential of pancreatic cancer. Cancer Res 63: 6265-6271, 2003.
42. Resnick MB, Konkin T, Routhier J, Sabo E and Pricolo VE: Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18: 511-518, 2005.
43. Shiou SR, Singh AB, Moorthy K, Datta PK, Washington MK, Beauchamp RD and Dhawan P: SMAD4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells. Cancer Res 67: 1571-1579, 2007. (Pubitemid 46383381)
44. Miwa N, Furuse M, Tsukita S, Niikawa N, Nakamura Y and Furukawa Y: Involvement of claudin-1 in the beta-catenin/TCF signaling pathway and its frequent up-regulation in human colorectal cancers. Oncol Res 12: 469-476, 2001.
45. Mankertz J, Hillenbrand B, Tavalali S, Huber O, Fromm M and Schulzke JD: Functional crosstalk between WNT signaling and CDX-related transcriptional activation in the regulation of the claudin-2 promoter activity. Biochem Biophys Res Commun 314: 1001-1007, 2004.